SILVIA NILO: Open Payments
NPI 1043099781 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,514 in 64 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $702 · 2025 $1,514
Food & beverage: $1,514
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $322 |
| Daiichi Sankyo Inc. | 5 | $117 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $86 |
| Incyte Corporation | 3 | $85 |
| PFIZER INC. | 4 | $82 |
| Astellas Pharma US Inc | 3 | $70 |
| TerSera Therapeutics LLC | 2 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Genentech USA, Inc. | 2 | $62 |
Products named: RYBREVANT, NERLYNX, JAKAFI, DATROWAY, Vyloy, Enhertu, Zoladex, Nubeqa.
Industry payments across FL — which companies pay providers there.
